Related Experiment Videos
Does apolipoprotein E (Apo-E) genotype influence nicotinic receptor binding in Alzheimer's disease
R T Reid1, M N Sabbagh, L J Thal
1Erik and Ese Banck Clinical Research Center, San Diego, CA, USA.
Journal of Neural Transmission (Vienna, Austria : 1996)
|November 22, 2001
Summary
The apolipoprotein E4 genotype does not affect the loss of high-affinity nicotinic acetylcholine receptors (nAChR) in Alzheimer's disease (AD). This study found no difference in nAChR binding across different Apo-E genotypes in AD patients.
Area of Science:
- Neuroscience
- Genetics
- Pharmacology
Background:
- Alzheimer's disease (AD) is characterized by significant loss of high-affinity nicotinic acetylcholine receptors (nAChR).
- The influence of apolipoprotein E (Apo-E) genotype, particularly the epsilon4 allele, on this cholinergic deficit in AD is debated.
- Previous research suggests a potential link between Apo-E4 gene dose and the extent of nAChR loss.
Purpose of the Study:
- To investigate the impact of apolipoprotein E (Apo-E) genotype on the reduction of high-affinity nicotinic acetylcholine receptor (nAChR) binding in Alzheimer's disease (AD).
- To clarify the controversial relationship between epsilon4 allele gene dose and cholinergic system changes in AD patients.
Main Methods:
- Comparison of midfrontal cortex tissue from three groups of autopsy-confirmed AD subjects based on Apo-E genotype: epsilon-/epsilon-, epsilon4/epsilon-, and epsilon4/epsilon4.
- Quantification of high-affinity nAChR binding using the radioligand [3H]-epibatidine ([3H]-Epi).
- Determination of Apo-E genotype from blood samples or post-mortem tissue.
Main Results:
- No significant difference in mean age at death was observed among the three Apo-E genotype groups (p = 0.19).
- Total [3H]-Epi binding, indicative of high-affinity nAChR, showed no significant variation across the epsilon-/epsilon- (6.7 +/- 4.6), epsilon4/epsilon- (6.1 +/- 2.4), and epsilon4/epsilon4 (6.0 +/- 1.0 fmol/mg protein) groups.
- These findings indicate that the presence or absence of the Apo-E4 genotype does not influence the degree of high-affinity nAChR loss in Alzheimer's disease.
Conclusions:
- The apolipoprotein E4 genotype does not appear to be a determinant factor in the observed loss of high-affinity nicotinic acetylcholine receptors in the brains of Alzheimer's disease patients.
- This study suggests that other genetic or environmental factors may play a more significant role in modulating cholinergic deficits associated with AD.
- Further research is warranted to fully elucidate the complex interplay of genetic factors and neurodegeneration in Alzheimer's disease pathogenesis.